BAKU, Azerbaijan, September 13. Israel's Biopharmax Group Ltd. setting up its Azerbaijani branch intends to export products to Kazakhstan, Kyrgyzstan, Uzbekistan, and Belarus, Biopharmax CEO Sarel Chen-Tov told Trend.
According to him, the company won't be limited to the mentioned markets and aims to expand its exports to other former Soviet states.
"On top of that, Biopharmax is determined to establish an appropriate transport and logistics infrastructure to implement the relevant initiative," Sarel Chen-Tov said.
BioPharmax is a leading international design and construction company of Pharmaceutical, Biotechnological and Chemical (API) plants, which is supposed to produce drugs and medical devices in Azerbaijan. The company also considers setting up the corresponding laboratory center jointly with Azerbaijani medical institutions and universities.